Department of ENT and Head and Neck Surgery, Lariboisière Hospital, Paris, France.
Department ENT - Sydney Adventist Hospital, University of Sydney, Australia.
Acta Otolaryngol. 2023 Mar;143(3):231-236. doi: 10.1080/00016489.2023.2186482. Epub 2023 Mar 20.
The surgical treatment of otosclerosis consists of the replacement of the stapes using a piston.
AIMS/OBJECTIVES: The objective of this study is to assess the audiometric results and quality of life (QOL) of patients who underwent surgery for otosclerosis by stapedectomy with fascia interposition (STIP) or by stapedotomy using CO laser (SLaser) without fascia interposition.
Ninety-one patients operated on for otosclerosis by STIP (40 patients) and by SLaser (51 patients) were included. Audiometric results were graphically displayed using the Amsterdam Hearing Evaluation Plot and were compared to the Common Otology Database (COD) comprising 660 patients. The patients' QOL was assessed with an otological validated survey. The significance level was < .05.
There was no significant difference in hearing improvement between SLaser and STIP-operated patients. There was no significant difference between our results and that of COD. QOL was significantly improved (+3.5/10) postoperatively for both STIP and SLaser in both social and professional fields.
By comparing QOL and hearing gain of STIP and SLaser, our results suggest that both surgical techniques are a safe and successful treatment for otosclerotic stapes fixation. Further studies aiming at comparing larger series may confirm and refine these results.
耳硬化症的手术治疗包括使用活塞置换镫骨。
目的/目标:本研究的目的是评估接受镫骨切除术联合筋膜间置术(STIP)或 CO 激光镫骨切开术(SLaser)治疗耳硬化症患者的听力结果和生活质量(QOL),其中 SLaser 手术不进行筋膜间置。
共纳入 91 例接受 STIP(40 例)和 SLaser(51 例)治疗的耳硬化症患者。使用阿姆斯特丹听力评估图直观显示听力结果,并与包含 660 例患者的常见耳科学数据库(COD)进行比较。采用经耳科学验证的调查问卷评估患者的 QOL。显著性水平为<.05。
SLaser 和 STIP 手术患者的听力改善无显著差异。我们的结果与 COD 无显著差异。STIP 和 SLaser 术后患者的 QOL 在社会和职业领域均显著改善(+3.5/10)。
通过比较 STIP 和 SLaser 的 QOL 和听力增益,我们的结果表明,这两种手术技术都是治疗耳硬化症镫骨固定的安全有效的方法。进一步旨在比较更大系列的研究可能会证实和完善这些结果。